These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18156315)

  • 1. Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes.
    Börner C; Bedini A; Höllt V; Kraus J
    Mol Pharmacol; 2008 Mar; 73(3):1013-9. PubMed ID: 18156315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids.
    Börner C; Höllt V; Sebald W; Kraus J
    J Leukoc Biol; 2007 Jan; 81(1):336-43. PubMed ID: 17041005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human T cells induces upregulation of cannabinoid receptor type 1 transcription.
    Börner C; Höllt V; Kraus J
    Neuroimmunomodulation; 2007; 14(6):281-6. PubMed ID: 18287809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stat6 inhibits human interleukin-4 promoter activity in T cells.
    Georas SN; Cumberland JE; Burke TF; Chen R; Schindler U; Casolaro V
    Blood; 1998 Dec; 92(12):4529-38. PubMed ID: 9845517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells.
    Börner C; Höllt V; Kraus J
    Mol Pharmacol; 2006 Apr; 69(4):1486-91. PubMed ID: 16434616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.
    Börner C; Smida M; Höllt V; Schraven B; Kraus J
    J Biol Chem; 2009 Dec; 284(51):35450-60. PubMed ID: 19858202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
    Rockwell CE; Snider NT; Thompson JT; Vanden Heuvel JP; Kaminski NE
    Mol Pharmacol; 2006 Jul; 70(1):101-11. PubMed ID: 16611855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cannabinoid CB1 receptor upregulates Slc2a4 expression via nuclear factor-κB and sterol regulatory element-binding protein-1 in adipocytes.
    Furuya DT; Poletto AC; Freitas HS; Machado UF
    J Mol Endocrinol; 2012 Oct; 49(2):97-106. PubMed ID: 22735681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation.
    Zhou X; Jiang Y; Lu L; Ding Q; Jiao Z; Zhou Y; Xin L; Chou KY
    Immunology; 2007 Dec; 122(4):476-85. PubMed ID: 17645498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic mechanisms involved in the induction of the mu opioid receptor gene in Jurkat T cells in response to interleukin-4.
    Kraus J; Lehmann L; Börner C; Höllt V
    Mol Immunol; 2010; 48(1-3):257-63. PubMed ID: 20828825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes.
    Kraus J
    Ann N Y Acad Sci; 2012 Jul; 1261():1-6. PubMed ID: 22823387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras/Erk pathway positively regulates Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells.
    So EY; Oh J; Jang JY; Kim JH; Lee CE
    Mol Immunol; 2007 Jul; 44(13):3416-26. PubMed ID: 17433443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT6 transcription factor binding sites with mismatches within the canonical 5'-TTC...GAA-3' motif involved in regulation of delta- and mu-opioid receptors.
    Börner C; Wöltje M; Höllt V; Kraus J
    J Neurochem; 2004 Dec; 91(6):1493-500. PubMed ID: 15584925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of delta9-tetrahydrocannabinol and methanandamide in CB1 knockout and wild-type mice.
    Baskfield CY; Martin BR; Wiley JL
    J Pharmacol Exp Ther; 2004 Apr; 309(1):86-91. PubMed ID: 14718593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine.
    Börner C; Martella E; Höllt V; Kraus J
    Neuroimmunomodulation; 2012; 19(3):180-6. PubMed ID: 22262103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of the interleukin (IL)-2 receptor alpha chain (CD25) promoter region in human B lymphocytes.
    Hewitt EL; Ozanne BW; Cushley W
    Cytokine; 1997 Dec; 9(12):982-91. PubMed ID: 9417809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB1 receptor antagonism increases hippocampal acetylcholine release: site and mechanism of action.
    Degroot A; Köfalvi A; Wade MR; Davis RJ; Rodrigues RJ; Rebola N; Cunha RA; Nomikos GG
    Mol Pharmacol; 2006 Oct; 70(4):1236-45. PubMed ID: 16855179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell functional regions of the human IL-3 proximal promoter.
    Ryan GR; Vadas MA; Shannon MF
    Mol Reprod Dev; 1994 Oct; 39(2):200-7. PubMed ID: 7826623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.
    Bermúdez-Siva FJ; Serrano A; Diaz-Molina FJ; Sánchez Vera I; Juan-Pico P; Nadal A; Fuentes E; Rodríguez de Fonseca F
    Eur J Pharmacol; 2006 Feb; 531(1-3):282-4. PubMed ID: 16423347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.